Study shows lower dose of abiraterone acetate as effective for prostate cancer treatment

Pharmaceutical scientists, clinicians, nurses and pharmacists from the National University of Singapore (NUS) and National University Hospital (NUH) have shown that a reduced dose of abiraterone acetate is potentially as effective and safe as the standard regimen for prostate cancer patients.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup